1. Home
  2. CNXN vs HRMY Comparison

CNXN vs HRMY Comparison

Compare CNXN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PC Connection Inc.

CNXN

PC Connection Inc.

N/A

Current Price

$89.17

Market Cap

2.2B

ML Signal

N/A

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$37.91

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXN
HRMY
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
CNXN
HRMY
Price
$89.17
$37.91
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
★ $48.08
AVG Volume (30 Days)
136.8K
★ 965.8K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 0.92%
N/A
EPS Growth
N/A
★ 7.97
EPS
★ 3.23
1.84
Revenue
N/A
★ $868,453,000.00
Revenue This Year
$8.32
$18.17
Revenue Next Year
$2.39
$13.71
P/E Ratio
$26.89
★ $20.59
Revenue Growth
N/A
★ 21.51
52 Week Low
$54.97
$25.90
52 Week High
$96.91
$43.49

Technical Indicators

Market Signals
Indicator
CNXN
HRMY
Relative Strength Index (RSI) 44.03 50.13
Support Level $85.81 $36.74
Resistance Level $88.31 $39.40
Average True Range (ATR) 2.85 1.50
MACD -0.52 0.17
Stochastic Oscillator 33.39 80.36

Price Performance

Historical Comparison
CNXN
HRMY

About CNXN PC Connection Inc.

PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: